Columbus Circle Investors’s BioTelemetry, Inc. BEAT Stock Holding History

Columbus Circle Investors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,845	Closed	-$429K	–	190
2019 Q1	$429K	Sell	6,845 -39,323	-85%	-$2.7M	0.01%	146
2018 Q4	$2.76M	Sell	46,168 -5,197	-10%	-$312K	0.08%	128
2018 Q3	$3.31M	Buy	+51,365	New	+$2.87M	0.07%	158
2014 Q1	–	Sell	-81,360	Closed	-$646K	–	368
2013 Q4	$646K	Sell	81,360 -862,827	-91%	-$8.05M	﹤0.01%	275
2013 Q3	$9.36M	Buy	+944,187	New	+$7.43M	0.07%	226

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Columbus Circle Investors's BEAT Position: Q2 2019 in Review

Columbus Circle Investors sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 6,845 shares — an estimated $429K sold.

Columbus Circle Investors first reported a position in BEAT in Q3 2013 and held it in 5 quarters. The position peaked at $9.36M in Q3 2013. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Columbus Circle Investors reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Columbus Circle Investors sold 6,845 BioTelemetry, Inc. shares in Q2 2019, an estimated $429K.
Columbus Circle Investors first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 5 quarters.
Columbus Circle Investors's BioTelemetry, Inc. position peaked at $9.36M in Q3 2013.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Columbus Circle Investors's 13F filing for Q2 2019, filed 2 Aug 2019.